Home > Online Clinic News > Spedra (Avanafil) Quick Onset Confirmed in Study

Latest News

Back in April we announced that Spedra was expected to be available soon in Europe. The medication for patients with erectile dysfunction is owned by the pharmaceutical company Vivus and in the US is called Stendra.

Vivus has claimed that this medication is effective within as little as 15 minutes. This month the company has published the results of the study and it has confirmed that the drug has does indeed have this rapid onset. Patients on this treatment actually achieved erections in as little as 10 minutes.

The active ingredient in this medication is called Avanafil and it acts as any other PDE5 inhibitor. Specifically, this type of medication relaxes and opens the blood vessels in the penis, causing the blood to enter the organ and distend it. Since it takes much less time for Avanafil to be effective (compared with Viagra and any other PDE5 inhibitor), many men might prefer it once it is actually on the market. We will keep you updated on the progress of getting this medication onto the European market, which is expected to be later this year.

More information can be read here.





 
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close